# Study to Collect Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity

> **NCT00106912** · — · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 35 (—)

## Conditions studied

- Fabry Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00106912
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03-28
- **Primary completion:** —
- **Final completion:** 2008-03-27
- **Target enrollment:** 35 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00106912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00106912, "Study to Collect Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00106912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*